Circulating markers of abdominal aortic aneurysm presence and progression.
作者信息
Golledge Jonathan, Tsao Philip S, Dalman Ronald L, Norman Paul E
机构信息
Vascular Biology Unit, Department of Surgery, School of Medicine, James Cook University, Townsville, Queensland, Australia.
出版信息
Circulation. 2008 Dec 2;118(23):2382-92. doi: 10.1161/CIRCULATIONAHA.108.802074.
Abstract
摘要
相似文献
1
Circulating markers of abdominal aortic aneurysm presence and progression.
Circulation. 2008 Dec 2;118(23):2382-92. doi: 10.1161/CIRCULATIONAHA.108.802074.
2
Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation.
Nat Rev Cardiol. 2009 Aug;6(8):543-52. doi: 10.1038/nrcardio.2009.102. Epub 2009 Jun 23.
3
Challenges of applying circulating biomarkers for abdominal aortic aneurysm progression.
Exp Biol Med (Maywood). 2021 May;246(9):1054-1059. doi: 10.1177/1535370221992530. Epub 2021 Feb 27.
4
The Association of Biomarkers of Inflammation and Extracellular Matrix Degradation With the Risk of Abdominal Aortic Aneurysm: The ARIC Study.
Angiology. 2019 Feb;70(2):130-140. doi: 10.1177/0003319718785278. Epub 2018 Jun 26.
5
Surrogate Markers of Abdominal Aortic Aneurysm Progression.
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):236-44. doi: 10.1161/ATVBAHA.115.306538. Epub 2015 Dec 29.
6
Metformin does not reduce inflammation in diabetics with abdominal aortic aneurysm or at high risk of abdominal aortic aneurysm formation.
Vascular. 2018 Dec;26(6):608-614. doi: 10.1177/1708538118777657. Epub 2018 Jun 5.
7
Diabetes mellitus and abdominal aortic aneurysms: A review of the mechanisms underlying the negative relationship.
Diab Vasc Dis Res. 2018 Sep;15(5):367-374. doi: 10.1177/1479164118780799. Epub 2018 Jun 6.
8
Inflammatory markers associated with abdominal aortic aneurysm.
Eur Cytokine Netw. 2016 Sep 1;27(3):75-80. doi: 10.1684/ecn.2016.0381.
9
Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution.
Am J Pathol. 2006 Mar;168(3):1022-30. doi: 10.2353/ajpath.2006.050868.
10
Current Prognostic Biomarkers for Abdominal Aortic Aneurysm: A Comprehensive Scoping Review of the Literature.
Biomolecules. 2024 Jun 5;14(6):661. doi: 10.3390/biom14060661.
引用本文的文献
1
Diagnostic Value of Protein C Depletion in Pathologies Associated with the Activation of the Blood Coagulation System.
Int J Mol Sci. 2025 Jun 25;26(13):6122. doi: 10.3390/ijms26136122.
2
Role of Macrophage Polarization in Chronic Rhinosinusitis Based on the Yin-Yang Theory: A Review.
J Inflamm Res. 2025 Jun 13;18:7813-7825. doi: 10.2147/JIR.S514060. eCollection 2025.
3
Pilot first-in-human CCR2 PET/CT to detect abdominal aortic aneurysm wall instability.
Theranostics. 2025 Apr 13;15(12):5518-5528. doi: 10.7150/thno.108656. eCollection 2025.
4
Cellular Senescence Genes as Cutting-Edge Signatures for Abdominal Aortic Aneurysm Diagnosis: Potential for Innovative Therapeutic Interventions.
J Cell Mol Med. 2025 Jan;29(2):e70323. doi: 10.1111/jcmm.70323.
5
D-Dimers and MPO Are No Suitable Biomarkers for Application in Abdominal Aortic Aneurysm (AAA) Surveillance in a Real-World Setting of Vascular Surgery Patients.
Biomolecules. 2024 Nov 28;14(12):1525. doi: 10.3390/biom14121525.
6
New Trends of Personalized Medicine in the Management of Abdominal Aortic Aneurysm: A Review.
J Pers Med. 2024 Dec 10;14(12):1148. doi: 10.3390/jpm14121148.
7
Circulating monocyte populations as biomarker for abdominal aortic aneurysms: a single-center retrospective cohort study.
Front Immunol. 2024 Jul 30;15:1418625. doi: 10.3389/fimmu.2024.1418625. eCollection 2024.
8
Inflammatory Markers and Aortic Aneurysms: Exploring the Role of Hs-CRP and MHR in Ascending Aortic Aneurysm Development.
Int J Gen Med. 2024 Jul 1;17:2899-2905. doi: 10.2147/IJGM.S465873. eCollection 2024.
9
Innovation in pathogenesis and management of aortic aneurysm.
World J Exp Med. 2024 Jun 20;14(2):91408. doi: 10.5493/wjem.v14.i2.91408.
10
Pharmacological Inhibition of MMP-12 Exerts Protective Effects on Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice.
Int J Mol Sci. 2024 May 27;25(11):5809. doi: 10.3390/ijms25115809.
本文引用的文献
1
Measurement and determinants of infrarenal aortic thrombus volume.
Eur Radiol. 2008 Sep;18(9):1987-94. doi: 10.1007/s00330-008-0956-3. Epub 2008 Apr 15.
2
Medical management of small abdominal aortic aneurysms.
Circulation. 2008 Apr 8;117(14):1883-9. doi: 10.1161/CIRCULATIONAHA.107.735274.
3
Mining the plasma proteome for cancer biomarkers.
Nature. 2008 Apr 3;452(7187):571-9. doi: 10.1038/nature06916.
4
LDL size and subclasses in patients with abdominal aortic aneurysm.
Int J Cardiol. 2009 May 29;134(3):406-8. doi: 10.1016/j.ijcard.2007.12.082. Epub 2008 Mar 25.
5
von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.
Circulation. 2008 Mar 18;117(11):1449-59. doi: 10.1161/CIRCULATIONAHA.107.722827.
6
Elevated plasma MMP1 and MMP9 are associated with abdominal aortic aneurysm rupture.
Eur J Vasc Endovasc Surg. 2008 May;35(5):580-4. doi: 10.1016/j.ejvs.2007.12.004. Epub 2008 Jan 15.
7
Activated protein C-protein C inhibitor complex in patients with abdominal aortic aneurysms: is it associated with diameter and growth rate?
Vasc Endovascular Surg. 2008 Apr-May;42(2):135-40. doi: 10.1177/1538574407311108. Epub 2008 Jan 9.
8
Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice.
Gene Ther. 2008 Feb;15(3):224-32. doi: 10.1038/sj.gt.3303069. Epub 2007 Nov 22.
9
Obesity, adipokines, and abdominal aortic aneurysm: Health in Men study.
Circulation. 2007 Nov 13;116(20):2275-9. doi: 10.1161/CIRCULATIONAHA.107.717926. Epub 2007 Oct 29.
10
Fibrinolysis in patients with an abdominal aortic aneurysm with special emphasis on rupture and shock.
J Thromb Haemost. 2008 Jan;6(1):147-50. doi: 10.1111/j.1538-7836.2007.02791.x. Epub 2007 Oct 8.
Zotero 插件